Pharmacodynamic Model of Parathyroid Hormone Modulation by a Negative Allosteric Modulator of the Calcium-Sensing Receptor

被引:9
作者
Abraham, Anson K. [2 ]
Maurer, Tristan S. [1 ]
Kalgutkar, Amit S. [1 ]
Gao, Xiang [3 ]
Li, Mei [4 ]
Healy, David R. [4 ]
Petersen, Donna N. [4 ]
Griffith, David A. [5 ]
Mager, Donald E. [2 ]
机构
[1] Pfizer Inc, Pharmacokinet Pharmacodynam & Metab Dept, Groton, CT 06340 USA
[2] SUNY Buffalo, Dept Pharmaceut Sci, Amherst, NY USA
[3] Pfizer Inc, Clin Pharmacol, New London, CT USA
[4] Pfizer Inc, Dept Biol, Healthy Aging Translat Pharmacol, Groton, CT 06340 USA
[5] Pfizer Inc, Dept Chem, Healthy Aging Translat Pharmacol, Groton, CT 06340 USA
来源
AAPS JOURNAL | 2011年 / 13卷 / 02期
关键词
allosteric; bone; calcium sensing receptor; ionized calcium; osteoporosis; parathyroid hormone; pharmacodynamics; pharmacokinetics; BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; CA2+ RECEPTOR; IN-VIVO; SECRETION; OSTEOPOROSIS; RATS; ANTAGONIST; TRIAL; HISTOMORPHOMETRY;
D O I
10.1208/s12248-011-9266-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study, a pharmacodynamic model is developed, based on calcium-parathyroid hormone (PTH) homeostasis, which describes the concentration-effect relationship of a negative allosteric modulator of the calcium-sensing receptor (CaR) in rats. Plasma concentrations of drug and PTH were determined from plasma samples obtained via serial jugular vein sampling following single subcutaneous doses of 1, 5, 45, and 150 mg/kg to male Sprague-Dawley rats (n = 5/dose). Drug pharmacokinetics was described by a one-compartment model with first-order absorption and linear elimination. Concentration-time profiles of PTH were characterized using a model in which the compound allosterically modulates Ca(+2) binding to the CaR that, in turn, modulates PTH through a precursor-pool indirect response model. Additionally, negative feedback was incorporated to account for tolerance observed at higher dose levels. Model fitting and parameter estimation were conducted using the maximum likelihood algorithm. The proposed model well characterized the data and provided compound specific estimates of the K (i) and cooperativity constant (alpha) of 1.47 ng/mL and 0.406, respectively. In addition, the estimated model parameters for PTH turnover were comparable to that previously reported. The final generalized model is capable of characterizing both PTH-Ca(+2) homeostasis and the pharmacokinetics and pharmacodynamics associated with the negative allosteric CaR modulator. As such, the model provides a simple platform for analysis of drugs targeting the PTH-Ca(+2) system.
引用
收藏
页码:265 / 273
页数:9
相关论文
共 39 条
[11]  
D'Argenio DZ., 1997, ADAPT II user's guide
[12]   METABOLISM OF PARATHYROID-HORMONE IN ISOLATED PERFUSED RAT-KIDNEY AND LIVER COMBINED [J].
DAUGAARD, H ;
EGFJORD, M ;
OLGAARD, K .
KIDNEY INTERNATIONAL, 1990, 38 (01) :55-62
[13]   The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats [J].
Dobnig, H ;
Turner, RT .
ENDOCRINOLOGY, 1997, 138 (11) :4607-4612
[14]  
EHLERT FJ, 1988, MOL PHARMACOL, V33, P187
[15]  
Friedman P.A., 2006, GOODMAN GILMANS PHAR, V11th
[16]   PTH(1-84)/PTH(7-84): a balance of power [J].
Friedman, PA ;
Goodman, WG .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2006, 290 (05) :F975-F984
[17]   Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure [J].
Frolik, CA ;
Black, EC ;
Cain, RL ;
Satterwhite, JH ;
Brown-Augsburger, PL ;
Sato, M ;
Hock, JM .
BONE, 2003, 33 (03) :372-379
[18]   Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats [J].
Gowen, M ;
Stroup, GB ;
Dodds, RA ;
James, IE ;
Votta, BJ ;
Smith, BR ;
Bhatnagar, PK ;
Lago, AM ;
Callahan, JF ;
DelMar, EG ;
Miller, MA ;
Nemeth, EF ;
Fox, J .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (11) :1595-1604
[19]   The venus's-flytrap and cysteine-rich domains of the human Ca2+ receptor are not linked by disulfide bonds [J].
Hu, JX ;
Reyes-Cruz, G ;
Goldsmith, PK ;
Spiegel, AM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (10) :6901-6904
[20]  
JUPPNER HW, 2001, ENDOCRINOLOGY, P969